China Offers Up Luxury Investment With Lanvin Backdoor Listing Plan Key Takeaways: Benzinga · Mar 25, 2022
Fosun Reports $157 Million of China mRNA Vaccine Sales in 2021 BioNTech partner markets the advanced-tech inoculation in Hong Kong, Macao and Taiwan as regulators haven’t cleared the shots for the mainland Caixin Global · Mar 23, 2022
Fosun Luxury Arm Lanvin Plans New York SPAC Debut The luxury fashion company plans to list via a blank check merger with an affiliate of Primavera Capital Caixin Global · Mar 23, 2022